APA (7th ed.) Citation

Suciangto, W., Rasyid, H., Vicente, A. A., & Suciangto, W. Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies. Elsevier.

Chicago Style (17th ed.) Citation

Suciangto, William, Haerani Rasyid, Anastasya Angelica Vicente, and Winny Suciangto. Effectivity and Safety Profile of Tenapanor, a Sodium-hydrogen Exchanger Isoform 3 Inhibitor, as an Innovative Treatment for Hyperphosphatemia in Chronic Kidney Disease: A Systematic Review of Clinical Studies. Elsevier.

MLA (9th ed.) Citation

Suciangto, William, et al. Effectivity and Safety Profile of Tenapanor, a Sodium-hydrogen Exchanger Isoform 3 Inhibitor, as an Innovative Treatment for Hyperphosphatemia in Chronic Kidney Disease: A Systematic Review of Clinical Studies. Elsevier.